A Strategy Lab For Psychedelic Harm Response

We’re a 501c3 supporting public wellbeing at scale.

WHAT WE DO

Recognizing the transformative potential of psychedelic medicines, we leverage research and market data to lead multi-stakeholder strategic processes to anticipate, mitigate, and respond to psychedelic harms and improve patient outcomes. We have three core functions which are carried out in parallel, and all are done in deep relationship and iterative feedback with the broader ecosystem.

Research & Advocacy

Organize, Expand, & Communicate Knowledge

We find and provide essential data and knowledge on psychedelic risks, harm reduction, and response strategies to all stakeholders, and influence systems to meet public needs.

Stewardship

Strategic Leadership, Analysis, & Facilitation

We lay the strategic foundation for the psychedelic ecosystem, aligning the goals, actions, language, and metrics of stakeholders to yield a systemic improvement in public safety

INCUBATION

Design, Build, & Improve Solutions with Ecosystem

We work with the right people to fill gaps, improve existing solutions, or build the solutions ourselves, so that all public safety needs are met

Our Team

CEO

Stacey Wallin

Stacey’s an entrepreneur and strategist. She previously co-founded Numinus, led BC Tech’s strategic growth, and is founder and chair of CAIN, a national Canadian non-profit for tech incubators + accelerators.

Linkedin ▸

COO

Malcolm Garland

Malcolm's a social entrepreneur with a track record of leading ventures from inception to acquisition in tech and e-commerce. He's been a long time student and lover of traditional psychedelic medicine.